{"id":"W2292454252","doi":"10.1101/mcs.a000729","title":"Putative <i>BRAF</i> activating fusion in a medullary thyroid cancer","year":2015,"lang":"en","type":"article","venue":"Molecular Case Studies","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Simon Fraser University; University of British Columbia; St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre; Conquer Cancer Foundation","keywords":"Vandetanib; Medullary thyroid cancer; Cabozantinib; Medicine; Cancer research; Thyroid cancer; Calcitonin; Thyroid; Cancer; Proto-Oncogene Proteins c-ret; Malignancy; Targeted therapy; Fusion gene; Internal medicine; Oncology; Biology; Sorafenib; Gene; Receptor; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001474492,0.0001931992,0.0003853363,0.0000951982,0.00006643561,0.000009639973,0.00003012601,0.00004354064,0.000006867621],"category_scores_gemma":[0.000183357,0.0001497105,0.00007712712,0.0003066544,0.00006840521,0.00005428729,0.0001039668,0.0001369622,0.000008538845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004459803,"about_ca_system_score_gemma":0.0001333759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005797326,"about_ca_topic_score_gemma":0.000452069,"domain_scores_codex":[0.9989098,0.00006649095,0.0002090297,0.0003042752,0.0002595765,0.000250809],"domain_scores_gemma":[0.9994012,0.00006224003,0.00007071564,0.000164295,0.0001716142,0.0001299583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001787071,0.002874347,0.09270608,0.0007682938,0.005081266,0.574726,0.08808991,0.001820083,0.08028291,0.0008592287,0.02190498,0.1290998],"study_design_scores_gemma":[0.05096694,0.006985541,0.01486816,0.002995561,0.00203348,0.01681735,0.1468679,0.0007341851,0.7373422,0.002416878,0.01557304,0.002398805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9315816,0.06404196,0.00002594531,0.002570209,0.0001372001,0.0004138649,0.00001318246,0.00003892797,0.001177091],"genre_scores_gemma":[0.9962912,0.001556041,0.0005651598,0.001039272,0.00006918696,0.0003798477,0.000007882889,0.00002537951,0.00006598007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6570593,"threshold_uncertainty_score":0.6105018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06105305352261538,"score_gpt":0.3778822186260809,"score_spread":0.3168291651034655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}